ImmunoGen is a Massachusetts-based biotechnology company that develops and markets antibody-drug conjugate therapeutics for the treatment of cancer.
Business Model:
Revenue: $95.6M
Employees: 51-200
Address: 830 Winter Street
City: Waltham
State: MA
Zip: 02451
Country: US
ImmunoGen is a Massachusetts-based biotechnology company that develops and markets antibody-drug conjugate therapeutics for the treatment of cancer.
Contact Phone:
+17818950600
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
11/24/1989
Ticker Symbol:
IMGN
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 6/2011 | Post-IPO Equity | $2M | 5/2017 | Post-IPO Equity | $30M | 12/2011 | Post-IPO Equity | 1 | $20M |
Eli Lilly Eli Lilly |
11/2011 | Angel | $1M |
Amgen Inc. |
12/2021 | Post-IPO Equity | $295.7M | 10/2011 | Post-IPO Equity | $3M |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|